Incyte Corp [INCY] stock prices are up 0.62% to $97.63 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The INCY shares have gain 2.58% over the last week, with a monthly amount drifted -6.28%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on December 08, 2025, when Mizuho upgraded its rating to an Outperform but kept the price target unchanged to $121 for it. Previously, Guggenheim upgraded its rating to Buy on November 03, 2025, and kept the price target unchanged to $125. On October 08, 2025, downgrade downgraded it’s rating to Perform. Wells Fargo upgraded its rating to an Overweight but stick to its price target of $89 on August 06, 2025. Barclays initiated its recommendation with an Overweight and recommended $90 as its price target on August 01, 2025. Stifel upgraded its rating to Buy for this stock on June 16, 2025, but kept the price target unchanged to $107. In a note dated March 18, 2025, William Blair downgraded an Mkt Perform rating on this stock.
The stock price of Incyte Corp [INCY] has been fluctuating between $53.56 and $109.28 over the past year. Currently, Wall Street analysts expect the stock to reach $98.88 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $97.63 at the most recent close of the market. An investor can expect a potential return of 1.28% based on the average INCY price forecast.
Analyzing the INCY fundamentals
The Incyte Corp [NASDAQ:INCY] reported sales of 4.81B for trailing twelve months, representing a surge of 20.05%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.33%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.19, Equity is 0.3 and Total Capital is 0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 96.85 points at the first support level, and at 96.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 98.66, and for the 2nd resistance point, it is at 99.68.
Ratios To Look Out For
It’s worth pointing out that Incyte Corp [NASDAQ:INCY]’s Current Ratio is 3.20. In addition, the Quick Ratio stands at 3.13 and the Cash Ratio stands at 1.83. Considering the valuation of this stock, the price to sales ratio is 3.98, the price to book ratio is 4.12 and price to earnings (TTM) ratio is 16.38.
Transactions by insiders
Recent insider trading involved MICHAEL MORRISSEY, Officer, that happened on Dec 17 ’25 when 4323.0 shares were purchased. Officer, VIJAY IYENGAR completed a deal on Dec 16 ’25 to buy 13388.0 shares. Meanwhile, Officer MICHAEL MORRISSEY bought 54008.0 shares on Dec 16 ’25.
